49th Annual Meeting of the American Academy of Child & Adolescent Psychiatry. 22-27 October 2002, San Francisco, CA, USA.
The diverse programme covered recent advances in developmental neurobiology, genetics, psychotherapy and pharmacotherapy. Presentations included clinical consultation breakfasts, with experts in their specialities, clinical case conferences, media theatre events, symposia, special interest groups, workshops and poster presentations. Several awards were presented to members to acknowledge their research achievements and service to the academy, and to children in need. All the presentations were focused on keeping the clinician and the researcher up-to-date on the advancements within the field of child and adolescent psychiatry. This report will focus on the new research poster presentations, which highlight the current status of paediatric pharmacotherapy. The data will be presented within the major diagnostic groups of the affective, behavioural, anxiety and developmental, autistic and psychotic syndromes. In paediatric pharmacotherapy particularly, several agents are administered as broad spectrum pharmacotherapeutics, and therefore, are used across several disorders.
Ambrosini
P J
PJ
Drexel University College of Medicine, 3200 Henry Avenue, Philadelphia, PA 19129, USA. paul.ambrosini@drexel.edu
Elia
J
J
Rynn
M A
MA
D000293:Adolescent; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy*; D001321:Autistic Disorder / Q000188:drug therapy*; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy*; D002665:Child Psychiatry; D003226:Congresses as Topic; D006801:Humans; D012955:Societies, Medical; D014481:United States
D014150:Antipsychotic Agents